60079-77-8

Basic information

• Product Name: methyl 2-bromo-2-(4-bromophenyl)acetate
• Synonyms: methyl 2-bromo-2-(4-bromophenyl)acetate
• CAS NO: 60079-77-8
• Molecular Formula: C₉H₈Br₂O₂
• Molecular Weight: 307.96662
• Mol File: 60079-77-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 318.6±27.0 °C(Predicted)
• Appearance: /
• Density: 1.786±0.06 g/cm3(Predicted)
• CAS DataBase Reference: methyl 2-bromo-2-(4-bromophenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-bromo-2-(4-bromophenyl)acetate(60079-77-8)
• EPA Substance Registry System: methyl 2-bromo-2-(4-bromophenyl)acetate(60079-77-8)

Safety Data

• Hazardous Substances Data: 60079-77-8(Hazardous Substances Data)

Upstream product

• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 

Relevant articles and documents

Manganese/bipyridine-catalyzed non-directed C(sp3)–H bromination using NBS and TMSN3

A Mn(II)/bipyridine-catalyzed bromination reaction of unactivated aliphatic C(sp3)?H bonds has been developed using N-bromosuccinimide (NBS) as the brominating reagent. The reaction proceeded in moderate-to-good yield, even on a gram scale. The introduced bromine atom can be converted into fluorine and allyl groups.

JAK kinase inhibitor and application

The present invention discloses a compound having the following general formula (I). The present invention also discloses a JAK kinase inhibitor comprising the compound and application of the compoundin preparation of a medicament for treating JAK-associated diseases. The JAK kinase inhibitor can inhibit the biological activities of JAK1, JAK2, JAK3 and TYK2 kinases involved in various kinds of signal transduction, can effectively treat various inflammatory diseases and various JAK-mediated signal transduction-driven diseases, and has a very broad application prospect.

Modulators of methyl modifying enzymes, compositions and uses thereof

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.